Korsana Biosciences, Inc. (KRSA)
31.31
-2.12
(-6.34%)
USD |
NASDAQ |
Oct 23, 16:00
31.44
+0.14
(+0.43%)
After-Hours: 20:00
Korsana Biosciences EPS Diluted (Quarterly) : -2.890 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.890 |
| March 31, 2026 | -5.289 |
| December 31, 2025 | -1.464 |
| September 30, 2025 | -2.118 |
| June 30, 2025 | -0.7385 |
| March 31, 2025 | -3.914 |
| December 31, 2024 | 1.457 |
| September 30, 2024 | -2.004 |
| June 30, 2024 | -3.687 |
| March 31, 2024 | -4.328 |
| December 31, 2023 | -4.793 |
| September 30, 2023 | -23.53 |
| June 30, 2023 | -12.83 |
| March 31, 2023 | -447.41 |
| December 31, 2022 | -23.21 |
| September 30, 2022 | -33.80 |
| June 30, 2022 | -43.13 |
| March 31, 2022 | -41.84 |
| Date | Value |
|---|---|
| December 31, 2021 | -34.75 |
| September 30, 2021 | -36.51 |
| June 30, 2021 | -63.45 |
| March 31, 2021 | -55.04 |
| December 31, 2020 | -79.06 |
| September 30, 2020 | -82.06 |
| June 30, 2020 | -98.40 |
| March 31, 2020 | -102.35 |
| December 31, 2019 | -132.17 |
| September 30, 2019 | -139.40 |
| June 30, 2019 | -164.84 |
| March 31, 2019 | -190.99 |
| December 31, 2018 | -157.88 |
| September 30, 2018 | -149.63 |
| June 30, 2018 | -152.16 |
| March 31, 2018 | -129.18 |
| December 31, 2017 | -141.30 |
| September 30, 2017 | -128.68 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Climb Bio, Inc. | -0.1772 |
| Q32 Bio, Inc. | -0.4398 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.755M |
| Total Expenses (Quarterly) | 1.755M |
| Enterprise Value | 17.65M |
| Earnings Yield | -37.56% |
| Normalized Earnings Yield | -37.56 |